Headline
Weekend Link Love
Ah. The weekend. To celebrate the arrival of Saturday, I give you a short list of articles that you should really make an effort to read. Or at least skim. Or at the least click the link and read the title. You may very well wind up a more knowledgable and wealthy person. Enjoy. … Read entire article »
Featured
Genuine Parts Company (GPC) Dividend Stock Analysis
Genuine Parts Company (GPC) is major distributor of replacement car parts. It operates various distribution centers, import centers, … Read more »
Thomson Reuters (TRI) Dividend Stock Analysis
Thomson Reuters (TRI) is massive publishing company. It was formed in 2008 when Thomson acquired Reuters. Currently, TRI … Read more »
Teva (TEVA) Dividend Stock Analysis
Teva (Teva) is and Isreal based pharmaceutical manufacturer. It is the largest generic drug company in the world. … Read more »
Popular
Should Americans Be Forced to Save For Retirement?
I have previously written about American’s poor savings rates. Even the rich are only saving on average … Read more »
Frugality is Just a Tool – Nothing More
Frugal habits take many flavors, kind of like ice cream. There is the do it yourself (DIY) … Read more »
Achieving a 10% yield on cost in 10 years
Many dividend growth investors consider how long it will take a given stock to reach a 10% … Read more »
Latest
7 Ways to Increase Your Savings
The key to achieving financial independence is to save and invest money. That is obvious. What is often not so obvious is where those increased savings are going to come from. Below, I’ve outlined seven great ways that you can boost your savings rate … Read entire article »
Genuine Parts Company (GPC) Dividend Stock Analysis
Genuine Parts Company (GPC) is major distributor of replacement car parts. It operates various distribution centers, import centers, and rebuilding plants. Probably the best known brand under GPC is NAPA, which even the those people as clueless about cars as myself has heard of. GPC has operations in the US (87% of sales), Mexico (13% of sales), Canada, and Australia. GPC … Read entire article »
Weekend Link Love
Behold! A small list of articles that you should be reading. Enjoy. … Read entire article »
Placing a value on time
Time is a big concept in the early retirement and financial independence community. I think almost every blogger out there has written about it at least once, if not nauseatingly more. Since I’m blogging in that space, I suppose that I should lend my voice to the chorus. … Read entire article »
Thomson Reuters (TRI) Dividend Stock Analysis
Thomson Reuters (TRI) is massive publishing company. It was formed in 2008 when Thomson acquired Reuters. Currently, TRI has four business segments, Financial & Risk (56% of 2012 revenues), Legal (27%), Tax & Accounting (9%), and Intellectual Property & Science (7%). Geographically, revenues in 2011came from the Americas (58%), Europe, the Middle East and Africa (30%), and Asia (12%). In 2012, about 86% of … Read entire article »
Weekend Link Love
It’s that time of the week again, isn’t it? Where I dump a handful of articles worth reading on you. Another weekend, another collection of links. Enjoy. … Read entire article »
Revisiting Tracking Portfolio Returns
Up to this point, I’ve written two articles detailing systems for tracking my portfolio’s returns and comparing them to the S&P500. Both of these systems had strengths and flaws. Some great feedback from commenters on the previous articles prompted me to go back, combine the best features of both systems and create what is probably the best and most accurate … Read entire article »
Recent Buy – ONEOK Inc (OKE)
As part of my commitment to keep my readers up to date on my portfolio, I write up short posts describing my transactions. Recently, I purchased 26 shares of ONEOK Inc (OKE). … Read entire article »
Teva (TEVA) Dividend Stock Analysis
Teva (Teva) is and Isreal based pharmaceutical manufacturer. It is the largest generic drug company in the world. In addition to generic drugs, Teva produces several brand name drugs including Copaxone (for multiple sclerosis) and Agilect/Azilect (for Parkinson’s disease). Generic drugs accounted for about 51% of total sales in 2012, branded drugs for 40%, and OTC medications and other revenues for 9%. 51% of … Read entire article »
